1. Home
  2. Active Ingredient Index
  3. Trastuzumab

Active Ingredient Trastuzumab

Active Ingredient Details

What is Trastuzumab?

A humanized monoclonal antibody against the ERBB-2 RECEPTOR (HER2). As an ANTINEOPLASTIC AGENT, it is used to treat BREAST CANCER where HER2 is overexpressed.

What is the usage for Trastuzumab?

Trastuzumab is used to treat certain breast or stomach cancers that produce more than the normal amount of a certain substance called HER2 protein. Trastuzumab belongs to a class of medications known as monoclonal antibodies. It works by slowing or stopping the growth of cancer cells. This monograph is about the following trastuzumab products: trastuzumab, trastuzumab-anns, trastuzumab-dkst, trastuzumab-dttb, trastuzumab-pkrb, trastuzumab-qyyp.

How many products in the NDC database contain Trastuzumab?

The NDC database has 18 products with the active ingredient Trastuzumab. The following table lists all the products that have this active ingredient.

NDC Products with Trastuzumab

NDC Proprietary Name Non-Proprietary Name Dosage Form Route Name Company Name Status
0069-0308Proprietary Name: Trazimera Trastuzumab-qyypInjection, Powder, Lyophilized, For SolutionIntravenousPfizer Laboratories Div Pfizer IncACTIVE
50242-077Proprietary Name: Herceptin Hylecta Trastuzumab And Hyaluronidase-oyskInjection, SolutionSubcutaneousGenentech, Inc.ACTIVE
50242-132Proprietary Name: Herceptin TrastuzumabInjection, Powder, Lyophilized, For SolutionIntravenousGenentech, Inc.ACTIVE
50242-133Proprietary Name: TrastuzumabSolutionGenentech, Inc.ACTIVE
50242-245Proprietary Name: Phesgo Pertuzumab, Trastuzumab, And Hyaluronidase-zzxfInjection, SolutionSubcutaneousGenentech, Inc.ACTIVE
50242-260Proprietary Name: Phesgo Pertuzumab, Trastuzumab, And Hyaluronidase-zzxfInjection, SolutionSubcutaneousGenentech, Inc.ACTIVE
55513-132Proprietary Name: Kanjinti Trastuzumab-annsInjection, Powder, Lyophilized, For SolutionIntravenousAmgen IncACTIVE
55513-141Proprietary Name: Kanjinti Trastuzumab-annsInjection, Powder, Lyophilized, For SolutionIntravenousAmgen IncACTIVE
63459-303Proprietary Name: Herzuma TrastuzumabInjection, Powder, Lyophilized, For SolutionIntravenousCephalon, Inc.ACTIVE
63552-037Proprietary Name: TrastuzumabInjection, Powder, Lyophilized, For SolutionPatheon Manufacturing Services LlcACTIVE
67457-991Proprietary Name: Ogivri TrastuzumabInjection, Powder, Lyophilized, For SolutionIntravenousMylan Institutional LlcACTIVE
68225-106Proprietary Name: TrastuzumabInjection, Powder, Lyophilized, For SolutionPatheon Italia S.p.a.ACTIVE
78206-147Proprietary Name: Ontruzant TrastuzumabInjection, Powder, Lyophilized, For SolutionIntravenousOrganon LlcACTIVE
78848-006Proprietary Name: TrastuzumabInjectionFarevaACTIVE
78848-007Proprietary Name: TrastuzumabInjectionFarevaACTIVE
83012-020Proprietary Name: EnhertuLiquidBoehringer Ingelheim Fremont, Inc.ACTIVE
83257-001Proprietary Name: Ogivri Trastuzumab-dkstInjection, Powder, Lyophilized, For SolutionIntravenousBiocon Biologics Inc.ACTIVE
83257-003Proprietary Name: Ogivri Trastuzumab-dkstInjection, Powder, Lyophilized, For SolutionIntravenousBiocon Biologics Inc.ACTIVE
<